Cystic fibrosis related diabetes (CFRD) in the era of modulators: A scoping review
Authors:
- 5 December 2022
- journal article
- review article
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 46, 23-29
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot studyPediatric Diabetes, 2013
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationNew England Journal of Medicine, 2011
- Clinical Care Guidelines for Cystic Fibrosis–Related DiabetesDiabetes Care, 2010
- Epidemiology, Pathophysiology, and Prognostic Implications of Cystic Fibrosis–Related DiabetesDiabetes Care, 2010
- Impaired Fasting Glucose in Cystic FibrosisDiabetes Care, 2010
- Cytokines in the Progression of Pancreaticβ-Cell DysfunctionInternational Journal of Endocrinology, 2010
- Oral glucose tolerance testing in children with cystic fibrosisPediatric Diabetes, 2010
- Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and MortalityDiabetes Care, 2009
- Inflammation and insulin resistanceFEBS Letters, 2007
- New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis: Fig. 1—European Respiratory Journal, 2005